Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer
Anticancer Research · 2023-02 · 43 (2) · 725-732
DOI: 10.21873/anticanres.16211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 25.01.2023. Verfasst von Mizuki Yamazaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Community Healthcare Pharmacy, Gifu Pharmaceutical University, Gifu, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Community Healthcare Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.
- Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
- Laboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, Gifu, Japan.
- Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu, Japan.
- Laboratory of Analytical and Bio-Analytical Chemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
- Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.
Zitieren
APA
Yamazaki, M., Komizo, N., Iihara, H., Hirose, C., Yanase, K., Yamada, Y., Endo, J., Yamashita, S., Ohno, Y., Todoroki, K., Suzuki, A., & Hayashi, H. (2023). Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer. Anticancer Research, 43(2), 725-732. https://doi.org/10.21873/anticanres.16211
Vancouver
Yamazaki M, Komizo N, Iihara H, Hirose C, Yanase K, Yamada Y, et al. Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer. Anticancer Research. 2023;43(2):725-732. doi:10.21873/anticanres.16211
BibTeX
@article{Yamazaki2023,
author = {Yamazaki, Mizuki and Komizo, Nao and Iihara, Hirotoshi and Hirose, Chiemi and Yanase, Komei and Yamada, Yuto and Endo, Junki and Yamashita, Shuji and Ohno, Yasushi and Todoroki, Kenichiro and Suzuki, Akio and Hayashi, Hideki},
title = {Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer},
journal = {Anticancer Research},
year = {2023},
volume = {43},
number = {2},
pages = {725--732},
doi = {10.21873/anticanres.16211}
}
EUVIMED